Related Experiment Video
Updated: Mar 27, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
1.4K
Rho Kinases in Autoimmune Diseases
Alessandra B Pernis1,2,3,4, Edd Ricker1,2, Chien-Huan Weng1,5
1Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY 10021; email: pernisa@hss.edu , RozoC@hss.edu , YiW@hss.edu.
Annual Review of Medicine
|January 16, 2016
Summary
Rho kinases (ROCKs) are crucial for tissue repair and immune responses. Dysregulated ROCK activity links to autoimmune diseases, suggesting ROCK inhibitors as potential therapies.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Rho kinases (ROCKs) are serine-threonine kinases acting as downstream effectors for Rho GTPases.
- ROCKs are vital in coordinating tissue responses to injury by regulating diverse biological processes.
- Aberrant ROCK activity is linked to cardiovascular, renal, and fibrotic diseases.
Purpose of the Study:
- To provide an overview of ROCKs' function in immune cells.
- To discuss the emerging role of ROCKs in autoimmune disease pathogenesis.
- To explore therapeutic strategies targeting ROCK inhibition for autoimmune disorders.
Main Methods:
- Literature review of studies on ROCKs in immune cells and autoimmune diseases.
- Analysis of the role of ROCK signaling pathways in immune cell function.
- Examination of potential therapeutic approaches for ROCK inhibition.
Main Results:
- ROCKs play a significant role in regulating immune cell functions.
- Evidence suggests ROCKs are involved in the development of autoimmune diseases.
- ROCK inhibition presents a promising therapeutic avenue for autoimmune conditions.
Conclusions:
- ROCKs are critical regulators of immune responses and are implicated in autoimmune pathogenesis.
- Targeting ROCKs offers a potential therapeutic strategy for managing autoimmune diseases.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
13.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.8K
01:29Autoimmune Disorders
2.1K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K
01:26Receptor Tyrosine Kinases
20.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.7K
01:22PI3K/mTOR/AKT Signaling Pathway
6.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.3K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.8K
01:07MAPK Signaling Cascades
9.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K